Study guide
16.2 Concentrations, Dilutions & Alligation
APC Intern Written Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals
2 Legal Framework: PBS & Medicine Schedules
2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)
3 Legal Framework: Privacy, National Law & Pharmacy Board
3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards
4 Patient-Centred Medication Management
4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management
5 Primary Care & Judicious Use of Medicines
5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices
6 Dispensing & Clinical Appropriateness
6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes
7 Counselling & Acute Care
7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response
8 Therapeutics: Cardiovascular & Endocrine
8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders
9 Therapeutics: Infection, Respiratory & Gastrointestinal
9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health
10 Therapeutics: Neurology, Psychiatry & Pain
10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics
11 Therapeutics: Special Populations & Systems
11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment
12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology
12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management
13 Monitoring: Clinical Review
13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications
14 Monitoring: Safety & Adverse Drug Reactions
14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring
15 Compounding Medicines
15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations
16 Pharmaceutical Calculations
16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations
17 Promote Health & Well-Being
17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency
16.2 Concentrations, Dilutions & Alligation
Key Takeaways Explain This Topic AI
Percent w/v means grams of solute per 100 mL of solution; 1% w/v equals 10 mg/mL—convert before dosing calculations.
Use C1V1 = C2V2 for simple dilutions when amount of drug is conserved; final volume minus stock volume equals diluent to add if mixing by volume.
Alligation alternate finds relative parts of two strengths to achieve an intermediate strength; scale parts to the batch size required.
Ratio strength 1:1000 means 1 g in 1000 mL (for w/v solutions), equivalent to 1 mg/mL or 0.1% w/v for aqueous adrenaline-type examples.
Ethanol and other liquid dilutions still follow concentration × volume conservation; keep units consistent and state whether percent is v/v or w/v.
Last updated: August 2026
15.2 Concentrations, Dilutions & Alligation
Quick Answer: Concentration calculations tell you how much drug is in a given volume or mass , and dilution/alligation calculations tell you how to mix stocks to a target strength . Fluent conversions between % w/v, % w/w, mg/mL, and ratio strengths , plus C1V1 = C2V2 and alligation , are core Standard 3.4 skills. On FIB items, enter the exact numeric result (mL of stock, final volume, parts, or mg/mL) in the unit the stem requests.
Compounding and many clinical checks fail when “5%” is treated as a vague adjective rather than a defined quantity.
- Percentage strengths
- Weight in volume (% w/v)
% w/v = grams of solute in 100 mL of solution (used for solids dissolved in liquids).
- 5% w/v = 5 g in 100 mL
- In 50 mL of 5% w/v there are 2.5 g of solute
- Weight in weight (% w/w)
% w/w = grams of solute in 100 g of preparation (common for ointments and some powders).
- 2% w/w hydrocortisone cream ≈ 2 g drug in 100 g cream
- For 30 g of 2% w/w: drug mass = 0.02 × 30 = 0.6 g = 600 mg
Do not casually swap w/v and w/w: density is not always 1 g/mL for thick bases.
Volume in volume (% v/v)
% v/v = mL of liquid solute per 100 mL of solution (common for ethanol/water mixtures).
Bridge to mg/mL (high-yield)
For dilute aqueous solutions, a practical identity is:
1% w/v = 1 g/100 mL = 1000 mg/100 mL = 10 mg/mL
- % w/v mg/mL
- 0.1% 1 mg/mL
- 0.5% 5 mg/mL
- 1% 10 mg/mL
- 2% 20 mg/mL
- 5% 50 mg/mL
- Worked example A — % to mg/mL
Lidocaine 2% w/v as mg/mL:
2% = 2 × 10 = 20 mg/mL
Dose volume for 40 mg : 40 ÷ 20 = 2 mL .
Worked example B — mass in a given volume
How many milligrams of drug in 15 mL of 0.9% w/v sodium chloride?
- 0.9% w/v = 9 mg/mL
- 15 × 9 = 135 mg
- (Alternatively: 0.9 g/100 mL → 0.135 g in 15 mL = 135 mg.)
- Dilution formula: C1V1 = C2V2
When you dilute a solution without adding more drug, amount of solute is constant : C 1 V 1 = C 2 V 2 C_1 V_1 = C_2 V_2 C 1 V 1 = C 2 V 2
- C1, V1 = concentration and volume of stock used
- C2, V2 = concentration and volume of final product
Rearrangements:
- V1 = (C2 × V2) / C1 → volume of stock needed
- V2 = (C1 × V1) / C2 → final volume after diluting a fixed stock aliquot
- Diluent to add (by volume, ideal mixing) ≈ V2 − V1
Concentrations must be in the same units (both %, both mg/mL, etc.).
Worked example C — find final volume
You dilute 20 mL of 10% w/v to 2% w/v . What is V2?
- 10 × 20 = 2 × V2
- V2 = 200 / 2 = 100 mL
- Diluent to add ≈ 100 − 20 = 80 mL
FIB if asked for final volume: 100 (mL). If asked for diluent: 80 (mL).
Worked example D — stock volume for a batch
Prepare 200 mL of 5% from 20% stock.
- V1 = (5 × 200) / 20 = 1000 / 20 = 50 mL of 20% stock
- Diluent ≈ 200 − 50 = 150 mL
- Worked example E — mg/mL form
Stock 50 mg/mL , need 10 mg/mL in a final syringe volume of 5 mL .
- V1 = (10 × 5) / 50 = 1 mL stock
- Diluent = 4 mL (if final volume is 5 mL)
- Alligation (mixing two strengths)
Alligation alternate finds the relative parts of a higher-strength and lower-strength product to obtain an intermediate strength.
- Write: Higher % (H)
- \ parts of H = (T − L)
- Target % (T)
- / parts of L = (H − T)
- Lower % (L)
- Worked example F — classic alligation
Mix 10% and 2% to obtain 5% .
- Parts of 10% = 5 − 2 = 3
- Parts of 2% = 10 − 5 = 5
- Ratio 10% : 2% = 3 : 5
To make 80 mL of 5%:
- Total parts = 3 + 5 = 8
- Volume of 10% = (3/8) × 80 = 30 mL
- Volume of 2% = (5/8) × 80 = 50 mL
Check: drug from 10% = 0.10 × 30 = 3 g; from 2% = 0.02 × 50 = 1 g; total 4 g in 80 mL = 5% w/v . Good.
Worked example G — diluting with water (0%)
Mix 20% stock with water (0%) to make 5% .
- Parts of 20% = 5 − 0 = 5
- Parts of water = 20 − 5 = 15
- Ratio stock : water = 5 : 15 = 1 : 3
For 100 mL of 5%: stock = 25 mL, water = 75 mL (same result as C1V1: V1 = (5 × 100)/20 = 25 mL).
Alligation and C1V1 agree when one “strength” is zero; alligation shines when both components contain drug.
Ratio strengths
A ratio strength 1 : n (weight in volume) means 1 g of solute in n mL of solution .
Adrenaline (epinephrine) 1 : 1000 (classic emergency presentation):
- 1 g in 1000 mL = 1000 mg in 1000 mL = 1 mg/mL
- As % w/v: 1 g/1000 mL = 0.1 g/100 mL = 0.1% w/v
1 : 10 000 = 0.1 mg/mL = 0.01% w/v.
Worked example H — volume for a stated mass
How many mL of adrenaline 1 : 1000 provide 0.5 mg ?
- Concentration = 1 mg/mL
- Volume = 0.5 ÷ 1 = 0.5 mL
FIB: 0.5 (mL). Decimal accuracy is critical—entering 5 would be a ten-fold overdose pattern.
Ethanol and other liquid dilutions
Treat stated % v/v ethanol with the same conservation idea when diluting pure or concentrated alcohol with water to a target % v/v (ideal volumes are approximate in real mixing because of volume contraction, but exam arithmetic usually uses C1V1 = C2V2 ).
Worked example I — ethanol
Prepare 200 mL of 30% v/v ethanol from 95% v/v stock.
- V1 = (30 × 200) / 95 = 6000 / 95 ≈ 63.16 mL of 95% ethanol
- Make up to 200 mL with water (as directed by the formula method in the stem)
If the exam wants a rounded value, follow the stated precision (for example 63.2 mL to one decimal place). When practising FIB, calculate fully then apply the required rounding once at the end.
Worked example J — parts from a concentrated disinfectant concept
Need 1 L of 2% from 10% concentrate:
- V1 = (2 × 1000) / 10 = 200 mL concentrate
- Diluent = 800 mL (approximately, for volume makeup)
- FIB technique for concentration items
Confirm whether the answer is stock volume , final volume , diluent volume , or concentration .
Keep % and ratio conversions explicit: write “1% = 10 mg/mL” on scrap paper every time until automatic.
For alligation, compute parts first , then scale to batch size—do not scale before parts.
Sanity-check: final strength must lie between the two strengths mixed; final volume must be larger than stock volume when diluting down.
Concentrations, dilutions, and alligation convert labels into measurable recipes . Combined with Section 16.1 dosing, they let you move from “what strength is this?” to “how much do I measure?” without unit chaos—exactly what Standard 3.4 calculation items probe.